Cargando…

Pharmacogenetic variants and risk of remdesivir‐associated liver enzyme elevations in Million Veteran Program participants hospitalized with COVID‐19

Remdesivir is the first US Food and Drug Administration (FDA)‐approved drug for the treatment of coronavirus disease 2019 (COVID‐19). We conducted a retrospective pharmacogenetic study to examine remdesivir‐associated liver enzyme elevation among Million Veteran Program participants hospitalized wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tuteja, Sony, Yu, Zhihong, Wilson, Otis, Chen, Hua‐Chang, Wendt, Frank, Chung, Cecilia P., Shah, Shailja C., Hunt, Christine M., Suzuki, Ayako, Chanfreau, Catherine, Gorman, Bryan R., Joseph, Jacob, Luoh, Shiuh‐Wen, Napolioni, Valerio, Robinson‐Cohen, Cassianne, Tao, Ran, Zhou, Jin, Chang, Kyong‐Mi, Hung, Adriana M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347806/ https://www.ncbi.nlm.nih.gov/pubmed/35684976 http://dx.doi.org/10.1111/cts.13313

Ejemplares similares

Predicting Breast Cancer Risk for Women Veterans of African Ancestry in the Million Veteran Program
por: Luoh, Shiuh-Wen, et al.
Publicado: (2023)

Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users
por: Chanfreau-Coffinier, Catherine, et al.
Publicado: (2019)

CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) in the Million Veterans Program
por: Chanfreau-Coffinier, Catherine, et al.
Publicado: (2023)

Pharmacogenetic allele variant frequencies: An analysis of the VA’s Million Veteran Program (MVP) as a representation of the diversity in US population
por: Markianos, Kyriacos, et al.
Publicado: (2023)

72 Establishing a histologically defined NAFLD cohort in the Million Veteran Program for further genetic analyses
por: Mukherjee, Samiran, et al.
Publicado: (2023)

Phenome-Wide Association Study of UMOD Gene Variants and Differential Associations With Clinical Outcomes Across Populations in the Million Veteran Program a Multiethnic Biobank
por: Akwo, Elvis A., et al.
Publicado: (2022)

A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program
por: Verma, Anurag, et al.
Publicado: (2021)

259 Proton pump inhibitor use is not significantly associated with severe COVID-19 related outcomes after extensive covariate adjustment
por: Shah, Shailja C., et al.
Publicado: (2022)

Pharmacogenetic testing in the Veterans Health Administration: Policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee
por: Vassy, Jason L., et al.
Publicado: (2018)

Breast Cancer Medications and Vision: Effects of Treatments for Early-stage Disease
por: Eisner, Alvin, et al.
Publicado: (2011)

A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program
por: Verma, Anurag, et al.
Publicado: (2022)

Modeling the longitudinal changes of ancestry diversity in the Million Veteran Program
por: Wendt, Frank R., et al.
Publicado: (2023)

97856 Implementation of DPYD and UGT1A1 pharmacogenetic testing to guide chemotherapy dosing
por: Varughese, Lisa A., et al.
Publicado: (2021)

Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population
por: Verma, Shefali S., et al.
Publicado: (2022)

Genetic Architecture of Abdominal Aortic Aneurysm in the Million Veteran Program
por: Klarin, Derek, et al.
Publicado: (2020)

Diversity and Scale: Genetic Architecture of 2,068 Traits in the VA Million Veteran Program
por: Verma, Anurag, et al.
Publicado: (2023)

Overview of Efforts to Increase Women Enrollment in the Veterans Affairs Million Veteran Program
por: Whitbourne, Stacey B., et al.
Publicado: (2023)

Phenome-wide association of 1809 phenotypes and COVID-19 disease progression in the Veterans Health Administration Million Veteran Program
por: Song, Rebecca J., et al.
Publicado: (2021)

Self-reported physical functioning, cardiometabolic health conditions, and health care utilization patterns in Million Veteran Program enrollees with Traumatic Brain Injury Screening and Evaluation Program data
por: Clark, Alexandra L., et al.
Publicado: (2023)

Mapping eGFR loci to the renal transcriptome and phenome in the VA Million Veteran Program
por: Hellwege, Jacklyn N., et al.
Publicado: (2019)

Bi-Ancestral Depression GWAS in the Million Veteran Program and Meta-Analysis in >1.2 Million Subjects Highlights New Therapeutic Directions
por: Levey, Daniel F., et al.
Publicado: (2021)

Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation
por: Lau-Min, Kelsey S., et al.
Publicado: (2022)

Genome-wide Association Study of Peripheral Artery Disease in the Million Veteran Program
por: Klarin, Derek, et al.
Publicado: (2019)

1127. Effectiveness of Remdesivir as Treatment for COVID-19 Positive US Veterans
por: Jeyapalina, Sujee, et al.
Publicado: (2022)

Genome-wide and phenome-wide analysis of ideal cardiovascular health in the VA Million Veteran Program
por: Huang, Rose D. L., et al.
Publicado: (2022)

A multi-population phenome-wide association study of genetically-predicted height in the Million Veteran Program
por: Raghavan, Sridharan, et al.
Publicado: (2022)

Correlates of Risk for Disinhibited Behaviors in the Million Veteran Program Cohort
por: Barr, Peter B., et al.
Publicado: (2023)

Mendelian randomization study of diabetes and dementia in the Million Veteran Program
por: Litkowski, Elizabeth M, et al.
Publicado: (2023)

555. Utilization of Remdesivir for COVID-19 in the National Veterans Affairs Healthcare System
por: Caffrey, Aisling, et al.
Publicado: (2021)

Genome-wide association analyses of posttraumatic stress disorder and its symptom subdomains in the Million Veteran Program
por: Stein, Murray B., et al.
Publicado: (2021)

Leading causes of cardiovascular hospitalization in 8.45 million US veterans
por: Krishnamurthi, Nirupama, et al.
Publicado: (2018)

Trellis for efficient data and task management in the VA Million Veteran Program
por: Ross, Paul Billing, et al.
Publicado: (2021)

Diversity is key for cross-ancestry transferability of glaucoma genetic risk scores in Hispanic Veterans in the Million Veteran Program
por: Waksmunski, Andrea R., et al.
Publicado: (2023)

Genetics of Blood Lipids Among ~300,000 Multi-Ethnic Participants of the Million Veteran Program
por: Klarin, Derek, et al.
Publicado: (2018)

Genetic Loci Associated With COVID-19 Positivity and Hospitalization in White, Black, and Hispanic Veterans of the VA Million Veteran Program
por: Peloso, Gina M., et al.
Publicado: (2022)

Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program
por: Serper, Marina, et al.
Publicado: (2020)

Correction: Leading causes of cardiovascular hospitalization in 8.45 million US veterans
por: Krishnamurthi, Nirupama, et al.
Publicado: (2018)

Association of Nut Consumption with Risk of Stroke and Cardiovascular Disease: The Million Veteran Program
por: Ivey, Kerry L., et al.
Publicado: (2021)

Million Veteran Program’s response to COVID-19: Survey development and preliminary findings
por: Whitbourne, Stacey B., et al.
Publicado: (2022)

The Structure of Relationships between the Human Exposome and Cardiometabolic Health: The Million Veteran Program
por: Ivey, Kerry L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6qf1cag7prjppjca5poh2efq7k